Vascular Actions of AT1 Angiotensin Receptors Do Not Contribute to Albuminuria or Hyperfiltration in Diabetic Kidney Disease

Science

Behind the Science

Fluorescent tracer agents coupled with transdermal detection technology enable physiological monitoring.
More >>

How it Works

Bright fluorescent agents designed not to interact with the body are sensed through the skin.
More >>

R&D Platform

New clinical applications for fluorescent tracer agent-based systems are in development.
More >>

Product Pipeline

Clinical and preclinical studies are underway to advance the use of fluorescence to measure and monitor disease progression.
More >>

Patent Estate

Composition of matter, device, algorithm, process and method patents in the US, Europe and globally.
More >>

Preclinical

Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology.
More >>

Clinical

Clinically practical solutions which can reduce the cost of healthcare while improving the standard of care are the goal.
More >>

Preclinical

Preclinical Overview

Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology.
More >>

Preclinical Publications

Research using MediBeacon preclinical products is featured at scientific meetings worldwide.More >>

Exclusive Content

In-depth preclinical content for researchers .
Complete a form to gain access.
More >>

Focus Areas

Fluorescent agents engineered to not interact with the body have the potential to enable measurement and monitoring of vital organ systems.
More >>

Nephrology

GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate point of care methodology holds promise.
More >>

Gastroenterology

Increased intestinal permeability is implicated in inflammatory bowel disease. Rapid assessment of gut barrier function is a focus.
More >>

Ophthalmology

Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis.
More >>

Surgery

Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization.
More >>

In Discovery

Potential medical applications for fluorescent tracer agent-based systems are wide ranging and target important unmet patient needs.
More >>

Company

History

Technology whose development began inside leading medical technology companies is ready for human application.
More >>

People

Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health.
More >>

By the Numbers